← Back to Search

Behavioural Intervention

Inspiratory Muscle Training for Parkinson's Disease

N/A
Recruiting
Led By Kristen Barta, PT, PhD
Research Sponsored by University of St. Augustine for Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Physician's diagnosis of Parkinson's disease
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Awards & highlights

Study Summary

This trial will test if a maintenance inspiratory muscle training program can help people with PD keep their expiratory muscle strength.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
A doctor has diagnosed you with Parkinson's disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
6 minute walk test
Fatigue Impact Scale
blood pressure
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Inspiratory Muscle TrainingExperimental Treatment1 Intervention
involves the intervention portion of the study to improve strength of the cardiopulmonary system

Find a Location

Who is running the clinical trial?

University of St. Augustine for Health SciencesLead Sponsor
5 Previous Clinical Trials
370 Total Patients Enrolled
Kristen Barta, PT, PhDPrincipal InvestigatorThe University of St. Augustine for Health Sciences

Media Library

Inspiratory Muscle Training (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05287243 — N/A
Parkinson's Disease Research Study Groups: Inspiratory Muscle Training
Parkinson's Disease Clinical Trial 2023: Inspiratory Muscle Training Highlights & Side Effects. Trial Name: NCT05287243 — N/A
Inspiratory Muscle Training (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05287243 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to take part in this clinical experiment?

"This clinical trial seeks 40 participants aged between 30 and 99, who have been formally diagnosed with Parkinson's disease. Eligibility is contingent on a physician’s diagnosis of the neurological disorder."

Answered by AI

Does the eligibility for this clinical trial extend to those over two decades old?

"The eligibility requirements for this trial are restricted to those aged 30-99. There are 27 studies open to individuals under 18, while 485 opportunities exist for seniors above 65 years of age."

Answered by AI

What is the aggregate count of participants participating in this clinical trial?

"Affirmative. According to data on clinicaltrials.gov, this research project, initially posted on August 1st 2022 is actively searching for participants. A total of 40 recruits are needed from one medical facility."

Answered by AI

Are there any opportunities to participate in this study?

"Affirmative. Clinicaltrials.gov reveals that this clinical trial is actively seeking participants; it was initially posted on August 1st 2022 and has just been updated as of June 8th 2022. 40 individuals need to be recruited at one medical centre."

Answered by AI
~17 spots leftby Mar 2025